- All sections
- C - Chemistrymetallurgy
- C07H - Sugarsderivatives thereofnucleosidesnucleotidesnucleic acids
- C07H 21/00 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patent holdings for IPC class C07H 21/00
Total number of patents in this class: 4032
10-year publication summary
215
|
192
|
193
|
186
|
176
|
141
|
129
|
119
|
110
|
91
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Ionis Pharmaceuticals, Inc. | 890 |
102 |
The Regents of the University of California | 20137 |
68 |
F. Hoffmann-La Roche AG | 7947 |
63 |
Alnylam Pharmaceuticals, Inc. | 1143 |
56 |
Agilent Technologies, Inc. | 2632 |
51 |
Life Technologies Corporation | 3323 |
43 |
Monsanto Technology LLC | 8289 |
42 |
Illumina Cambridge Limited | 670 |
42 |
Illumina, Inc. | 3383 |
35 |
Isis Pharmaceuticals, Inc. | 208 |
35 |
Wave Life Sciences Ltd. | 178 |
31 |
The Trustees of the University of Pennsylvania | 4354 |
28 |
Hoffmann-La Roche Inc. | 3484 |
27 |
The General Hospital Corporation | 4781 |
27 |
Pacific Biosciences of California, Inc. | 763 |
27 |
The Trustees of Columbia University in the City of New York | 3592 |
25 |
President and Fellows of Harvard College | 6005 |
24 |
Gen-Probe Incorporated | 1001 |
24 |
Sarepta Therapeutics, Inc. | 383 |
23 |
Centre National de La Recherche Scientifique | 10576 |
20 |
Other owners | 3239 |